Named in honor of former Project ALS board member and inspiration Tom Kirchhoff, the Tom Kirchhoff Family Post-Doctoral Fellowship at Project ALS is given to promising young scientists already making a difference in ALS research. This April, the fellowship has been awarded to Emily Lowry, PhD, at Columbia University. Dr. Lowry currently works within the Project ALS Pre-Clinical Core at Columbia University, alongside Drs. Hynek Wichterle and Serge Przedborski, to identify and screen for potential ALS therapies. Emily has also helped to develop a novel compound in-house that has shown promise in several ALS models.
Dr. Lowry succeeds Joseph Klim, PhD, the first recipient of the Kirchhoff Fellowship. Thanks to the Kirchhoffs, Dr. Klim, a researcher in the Harvard laboratory of Kevin Eggan, made developments in identifying new therapeutic targets for ALS, including neuroinflammation, and the ALS proteasome.

A Statement From Lori Hermstad: On the Historic Results of the FUSION Trial for FUS-ALS.
Today, we hardly have words. After years of waiting, praying and hoping, the news we have dreamed of is finally here: the Phase 3 FUSION

